4‑methylumbelliferone inhibits clonogenic potency by suppressing high molecular weight‑hyaluronan in fibrosarcoma cells

Hasegawa,Kazuki; Saga,Ryo; Takahashi,Rei; Fukui,Roman; Chiba,Mitsuru; Okumura,Kazuhiko; Tsuruga,Eichi; Hosokawa,Yoichiro

doi:10.3892/ol.2020.11370

4‑methylumbelliferone inhibits clonogenic potency by suppressing high molecular weight‑hyaluronan in fibrosarcoma cells

Authors:
- Kazuki Hasegawa
- Ryo Saga
- Rei Takahashi
- Roman Fukui
- Mitsuru Chiba
- Kazuhiko Okumura
- Eichi Tsuruga
- Yoichiro Hosokawa
View Affiliations

Affiliations: Department of Radiation Sciences, Graduate School of Health Sciences, Hirosaki University, Mirosaki, Aomori 036‑8564, Japan, Department of Bioscience and Laboratory Medicine, Graduate School of Health Sciences, Hirosaki University, Hirosaki, Aomori 036‑8564, Japan, Department of Oral and Maxillofacial Surgery, School of Dentistry, Health Science University of Hokkaido, Tobetsu, Hokkaido 061‑0293, Japan
Published online on: February 5, 2020 https://doi.org/10.3892/ol.2020.11370
Pages: 2801-2808
Copyright: © Hasegawa et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The inflammatory response is closely associated with cancer cell survival. It has been reported that inflammatory signaling cascades promote tumor survival and exert detrimental effects in normal tissue. Hyaluronans have different cellular functions depending on their molecular weights and high molecular weight‑hyaluronan (HMW‑HA) exhibits anti‑inflammatory effects. A previous study determined that the co‑administration of 4‑methylumbelliferone (4‑MU) and X‑ray irradiation enhanced anti‑tumor and anti‑inflammatory effects in HT1080 human fibrosarcoma cells. However, many mechanisms underlie the effect of hyaluronan molecular weight on cells and the induction of anti‑inflammatory effects via 4‑MU. The present study aimed to determine the relationship between hyaluronan synthesis inhibition by 4‑MU and its anti‑inflammatory and radio‑sensitizing effect in the context of hyaluronan molecular weight. The hyaluronan concentration following 2 Gy X‑ray irradiation and/or 4‑MU administration was analyzed via ELISA. Additionally, the mRNA expressions of hyaluronan synthase (HAS) by 4‑MU and various inflammatory cytokines and interleukins (IL) following exogenous HMW‑HA administration were evaluated via Reverse transcription‑quantitative PCR. Invasive potential was assessed by matrigel transwell assays and cell survival following exposure to 4‑MU with HMW‑HA was determined using a clonogenic potency assay. The results of the present study demonstrated that 4‑MU suppressed HMW‑HA production by inhibiting HAS2 and HAS3 expression. In addition, the surviving fraction of fibrosarcoma cells were rescued from the cell‑killing effect of 4‑MU via the exogenous administration of HMW‑HA. The mRNA levels of certain inflammatory cytokines, including IL‑1α, IL‑36γ and IL‑37 were elevated following HMW‑HA administration. The surviving fraction of cells irradiated with 2 Gy alone did not increase following exogenous HMW‑HA administration. The results of the present study indicated that the radio‑sensitizing effect of 4‑MU and the inhibitory effect on hyaluronan synthesis were not closely associated. It was also revealed that IL‑1α, IL‑36γ and IL‑37 were associated with the cell‑killing effect of 4‑MU in HT1080 cells.

View Figures

View References

1	Hara T, Iwadate M, Tachibana K, Waguri S, Takenoshita S and Hamada N: Metastasis of breast cancer cells to the bone, lung, and lymph nodes promotes resistance to ionizing radiation. Strahlenther Onkol. 193:848–855. 2017. View Article : Google Scholar : PubMed/NCBI
2	Deorukhkar A and Krishnan S: Targeting inflammatory pathways for tumor radiosensitization. Biochem Pharmacol. 80:1904–1914. 2010. View Article : Google Scholar : PubMed/NCBI
3	Grivennikov SI, Greten FR and Karin M: Immunity, inflammation, and cancer. Cell. 140:883–899. 2010. View Article : Google Scholar : PubMed/NCBI
4	Michael C. Haffner, Chiara Berlato and Wolfgang Doppler: Exploiting our knowledge of NF-κB signaling for the treatment of mammary cancer. J Mammary Gland Biol Neoplasia. 11:63–73. 2006. View Article : Google Scholar : PubMed/NCBI
5	Yates TJ, Lopez LE, Lokeshwar SD, Ortiz N, Kallifatidis G, Jordan A, Hoye K, Altman N and Lokeshwar VB: Dietary supplement 4-methylumbelliferone: An effective chemopreventive and therapeutic agent for prostate cancer. J Natl Cancer Inst. 107:djv0852015. View Article : Google Scholar : PubMed/NCBI
6	Hiraga T, Ito S and Nakamura H: Cancer stem-like cell marker CD44 promotes bone metastases by enhancing tumorigenicity, cell motility, and hyaluronan production. Cancer Res. 73:4112–4122. 2013. View Article : Google Scholar : PubMed/NCBI
7	Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, Imagawa M, Shinomura T, Hamaguchi M, Yoshida Y, Ohnuki Y, et al: Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J Biol Chem. 274:25085–25092. 1999. View Article : Google Scholar : PubMed/NCBI
8	Itano N and Kimata K: Mammalian hyaluronan synthases. IUBMB Life. 54:195–199. 2002. View Article : Google Scholar : PubMed/NCBI
9	Passi A, Vigetti D, Buraschi S and Iozzo RV: Dissecting the role of hyaluronan synthases in the tumor microenvironment. FEBS J. 286:2937–2949. 2019. View Article : Google Scholar : PubMed/NCBI
10	Franklin O, Billing O, Öhlund D, Berglund A, Herdenberg C, Wang W, Hellman U and Sund M: Novel prognostic markers within the CD44-stromal ligand network in pancreatic cancer. J Pathol Clin Res. 5:130–141. 2019. View Article : Google Scholar : PubMed/NCBI
11	Li F, Hao P, Liu G, Wang W, Han R, Jiang Z and Li X: Effects of 4-methylumbelliferone and high molecular weight hyaluronic acid on the inflammation of corneal stromal cells induced by LPS. Graefes Arch Clin Exp Ophthalmol. 255:559–566. 2017. View Article : Google Scholar : PubMed/NCBI
12	Bharti R, Dey G and Mandal M: Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement. Cancer Lett. 375:51–61. 2016. View Article : Google Scholar : PubMed/NCBI
13	Takeda K, Fujii N, Nitta Y, Sakihara H, Nakayama K, Rikiishi H and Kumagai K: Murine tumor cells metastasizing selectively in the liver: Ability to produce hepatocyte-activating cytokines interleukin-1 and/or −6. Jpn J Cancer Res. 82:1299–1308. 1991. View Article : Google Scholar : PubMed/NCBI
14	Reichner JS, Mulligan JA, Palla ME, Hixson DC, Albina JE and Bland KI: Interleukin-6 production by rat hepatocellular carcinoma cells is associated with metastatic potential but not with tumorigenicity. Arch Surg. 131:360–365. 1996. View Article : Google Scholar : PubMed/NCBI
15	Saga R, Monzen S, Chiba M, Yoshino H, Nakamura T and Hosokawa Y: Anti-tumor and anti-invasion effects of a combination of 4-methylumbelliferone and ionizing radiation in human fibrosarcoma cells. Oncol Lett. 13:410–416. 2017. View Article : Google Scholar : PubMed/NCBI
16	Saga R, Hasegawa K, Murata K, Chiba M and Nakamura T: Okumura K, Tsuruga E and Hosokawa Y: Regulation of radiosensitivity by 4-methylumbelliferone via the suppression of interleukin-1 in fibrosarcoma cell. Oncol Lett. 17:3555–3561. 2019.PubMed/NCBI
17	Lokeshwar VB, Lopez LE, Munoz D, Chi A, Shirodkar SP, Lokeshwar SD, Escudero DO, Dhir N and Altman N: Antitumor activity of hyaluronic acid synthesis inhibitor 4-methylumbelliferone in prostate cancer cells. Cancer Res. 70:2613–2623. 2010. View Article : Google Scholar : PubMed/NCBI
18	Liu YY, Lee CH, Dedaj R, Zhao H, Mrabat H, Sheidlin A, Syrkina O, Huang PM, Garg HG, Hales CA, et al: High-molecular-weight hyaluronan--a possible new treatment for sepsis-induced lung injury: A preclinical study in mechanically ventilated rats. Crit Care. 12:R1022008. View Article : Google Scholar : PubMed/NCBI
19	Nazarenko I, Marhaba R, Reich E, Voronov E, Vitacolonna M, Hildebrand D, Elter E, Rajasagi M, Apte RN and Zöller M: Tumorigenicity of IL-1alpha- and IL-1beta-deficient fibrosarcoma cells. Neoplasia. 10:549–562. 2008. View Article : Google Scholar : PubMed/NCBI
20	Bridgewood C, Stacey M, Alase A, Lagos D, Graham A and Wittmann M: IL-36γ has proinflammatory effects on human endothelial cells. Exp Dermatol. 26:402–408. 2017. View Article : Google Scholar : PubMed/NCBI
21	Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, O'Toole M, Young DA, Fouser LA, Nickerson-Nutter C, Collins M, et al: Inter-regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: Implications in psoriasis pathogenesis. J Invest Dermatol. 131:2428–2437. 2011. View Article : Google Scholar : PubMed/NCBI
22	Buhl AL and Wenzel J: Interleukin-36 in Infectious and Inflammatory Skin Diseases. Front Immunol. 10:11622019. View Article : Google Scholar : PubMed/NCBI
23	Nold MF, Nold-Petry CA, Zepp JA, Palmer BE, Bufler P and Dinarello CA: IL-37 is a fundamental inhibitor of innate immunity. Nat Immunol. 11:1014–1022. 2010. View Article : Google Scholar : PubMed/NCBI
24	Tete S, Tripodi D, Rosati M, Conti F, Maccauro G, Saggini A, Cianchetti E, Caraffa A, Antinolfi P, Toniato E, et al: IL-37 (IL-1F7) the newest anti-inflammatory cytokine which suppresses immune responses and inflammation. Int J Immunopathol Pharmacol. 25:31–38. 2012. View Article : Google Scholar : PubMed/NCBI
25	Tamari Y, Kashino G and Mori H: Acquisition of radioresistance by IL-6 treatment is caused by suppression of oxidative stress derived from mitochondria after γ-irradiation. J Radiat Res (Tokyo). 58:412–420. 2017. View Article : Google Scholar
26	Chen Y, Zhang F, Tsai Y, Yang X, Yang L, Duan S, Wang X, Keng P and Lee SO: IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat Oncol. 10:2272015. View Article : Google Scholar : PubMed/NCBI
27	Duan S, Tsai Y, Keng P and Chen Y, Lee SO and Chen Y: IL-6 signaling contributes to cisplatin resistance in non-small cell lung cancer via the up-regulation of anti-apoptotic and DNA repair associated molecules. Oncotarget. 6:27651–27660. 2015. View Article : Google Scholar : PubMed/NCBI